HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $184,536 | -4.6% | 259,910 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $193,425 | +2.5% | 259,910 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $188,617 | -25.2% | 259,910 | 0.0% | 0.01% | -30.0% |
| Q3 2022 | $252,000 | -49.2% | 259,910 | 0.0% | 0.01% | -47.4% |
| Q2 2022 | $496,000 | -61.6% | 259,910 | 0.0% | 0.02% | -57.8% |
| Q1 2022 | $1,292,000 | -26.9% | 259,910 | +144.2% | 0.04% | -27.4% |
| Q4 2020 | $1,768,000 | -2.2% | 106,419 | 0.0% | 0.06% | -8.8% |
| Q3 2020 | $1,808,000 | – | 106,419 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |